Phase 4 Completed N=44 Randomized Quadruple-blind Treatment

The Treatment of Insomnia in Patients With HIV Disease

Source: ClinicalTrials.gov NCT00465972 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2013

Primary outcomePrimary: Response: Change in Insomnia Severity Rating Scale at 3 Months. — 0.72; -4.01 units on a scale

Summary

This study is designed to evaluate the efficacy of two commonly prescribed sleep aids for use in patients who are HIV positive and suffer from insomnia.

Outcome Measures

Outcome	Result	p-value
PRIMARY Response: Change in Insomnia Severity Rating Scale at 3 Months.	0.72; -4.01	—
SECONDARY Change in Piper Fatigue Scale at 3 Months	12; 17	—

Eligibility Criteria

Inclusion Criteria

Insomnia
HIV Seropositive
Stable HIV Disease

Exclusion Criteria

Other psychiatric illnesses
Unstable HIV disease

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00465972). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.